{
  "case_id": "Case_10",
  "model_id": "google/gemini-2.5-flash",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Post-Traumatic Stress Disorder (PTSD)\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"F43.10\",\n        \"reasoning\": \"The patient presents with classic symptoms of PTSD including insomnia, frequent nightmares, hypervigilance, and avoidance of discussing past experiences, all consistent with a history of trauma expected in an asylum seeker from Syria. Tearfulness when asked about family further supports trauma-related emotional distress.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Adjustment Disorder with Mixed Anxiety and Depressed Mood\",\n            \"confidence\": 0.7,\n            \"icd_code\": \"F43.23\",\n            \"reasoning\": \"The patient is an asylum seeker facing significant life changes and stressors. Symptoms like insomnia, difficulty concentrating, and emotional distress (tearfulness) could be a maladaptive response to these acute stressors and the migration process itself, especially if the full criteria for PTSD are not met.\"\n        },\n        {\n            \"name\": \"Major Depressive Disorder (MDD), Single Episode, Moderate\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"F32.1\",\n            \"reasoning\": \"Insomnia, difficulty concentrating, and tearfulness are common symptoms of depression. While nightmares and hypervigilance point more strongly to PTSD, MDD could coexist or be the primary diagnosis if the core symptoms of anhedonia or persistent low mood are present, which are not explicitly stated but could be underlying.\"\n        },\n        {\n            \"name\": \"Generalized Anxiety Disorder (GAD)\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"F41.1\",\n            \"reasoning\": \"Hypervigilance, difficulty concentrating, and insomnia can be symptoms of GAD. The persistent headaches could also be tension-related anxiety. However, the specific presence of nightmares and avoidance points away from GAD as a primary diagnosis, but it could be comorbid.\"\n        },\n        {\n            \"name\": \"Traumatic Brain Injury (TBI) sequelae\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"S06.90XA\",\n            \"reasoning\": \"Persistent headaches and difficulty concentrating could be residual symptoms of a past TBI, which is plausible in a conflict zone. While no specific history is given, it's important not to overlook physical causes for neurological symptoms. Physical exam was unremarkable, but subtle TBI effects might not be evident without specific testing.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Insomnia, frequent nightmares, hypervigilance\",\n        \"Avoidance of discussing past experiences, tearfulness when asked about family\",\n        \"Persistent headaches and difficulty concentrating\",\n        \"Asylum seeker from Syria, no prior mental health care history\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Structured Clinical Interview for DSM-5 (SCID-5) or Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)\",\n            \"purpose\": \"To formally assess for PTSD criteria and rule out other psychiatric disorders, ensuring a comprehensive diagnostic evaluation.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Comprehensive medical workup (CBC, CMP, TSH, Vitamin D, B12)\",\n            \"purpose\": \"To rule out underlying medical conditions contributing to fatigue, headaches, and concentration difficulties (e.g., anemia, thyroid dysfunction, nutritional deficiencies).\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Neuropsychological screening (e.g., MoCA, Mini-Cog)\",\n            \"purpose\": \"To objectively assess cognitive function (concentration, memory) and screen for potential organic causes like mild TBI or other neurological issues, given the complaints of difficulty concentrating and headaches.\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Establish therapeutic rapport and build trust, acknowledging the patient's experiences and cultural context.\",\n            \"Assess for immediate safety concerns (suicidal ideation, homicidal ideation, self-harm).\",\n            \"Provide psychoeducation on common stress responses and the impact of trauma, normalizing his symptoms.\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Sertraline (Zoloft)\",\n                \"dose\": \"25 mg daily, titrate to 50-100 mg daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Long-term (at least 6-12 months post-symptom improvement)\",\n                \"rationale\": \"First-line SSRI for PTSD and comorbid anxiety/depression. Start low and go slow due to potential for side effects and patient sensitivity.\"\n            },\n            {\n                \"drug\": \"Prazosin\",\n                \"dose\": \"1 mg at bedtime, titrate up to 5-10 mg at bedtime\",\n                \"route\": \"PO\",\n                \"duration\": \"Ongoing as needed for nightmares\",\n                \"rationale\": \"Alpha-1 adrenergic antagonist, effective in reducing nightmares and improving sleep quality in PTSD.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Symptom severity (PTSD, depression, anxiety, sleep disturbances, headaches)\",\n            \"Medication side effects and adherence\",\n            \"Safety (suicidal ideation, self-harm)\",\n            \"Functional impairment\",\n            \"Every 1-2 weeks initially, then monthly once stable\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Trauma-informed Psychotherapy (e.g., Trauma-Focused CBT, EMDR)\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Essential for processing trauma, developing coping skills, and reducing PTSD symptoms. Should be culturally sensitive and interpreter-assisted.\"\n            },\n            {\n                \"specialty\": \"Social Work/Case Management\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"To address practical needs related to asylum status, housing, legal aid, and community integration, which significantly impact mental well-being.\"\n            },\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"routine\",\n                \"reason\": \"If headaches persist or worsen, or if neuropsychological screening suggests a need for further evaluation for TBI or other neurological conditions.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Worsening nightmares or flashback frequency/intensity\",\n        \"Emergence of suicidal ideation or intent\",\n        \"Increased social isolation or functional decline\",\n        \"Signs of psychosis or severe dissociation\"\n    ],\n    \"patient_education\": [\n        \"Explain PTSD as a normal reaction to abnormal events, emphasizing that symptoms are not a sign of weakness.\",\n        \"Discuss the role of medication in managing symptoms and the importance of regular therapy sessions.\",\n        \"Encourage healthy coping mechanisms (e.g., mindfulness, gentle exercise, social connection) and self-care.\",\n        \"Emphasize the importance of adherence to treatment and regular follow-up appointments.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Weekly for the first 4-6 weeks to monitor medication and initiate therapy, then every 2-4 weeks.\",\n        \"conditions\": \"Immediate return if experiencing suicidal thoughts, severe panic attacks, uncontrolled nightmares, or significant worsening of symptoms.\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Lack of detailed trauma history due to avoidance, which could impact the specific therapeutic approach.\",\n        \"The exact duration and onset of symptoms, which are not specified.\",\n        \"Potential cultural barriers to treatment engagement and disclosure of sensitive information.\"\n    ]\n}\n```",
  "latency": 8.718584060668945,
  "timestamp": "2025-08-10T09:28:49.381395",
  "cached_at": "2025-08-10T09:28:49.381396"
}